Primary Site >> Colorectal Cancer

Gene >> AKT3

  • 2000
  • 2005
  • 2011
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.
PMID: 11085546
Ref: Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs.
PMID: 16128748
Ref: Functional specificity of Akt isoforms in cancer progression.
PMID: 25962016
Ref: Cell survival and metastasis regulation by Akt signaling in colorectal cancer.
PMID: 23603750
Ref: An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in Colorectal Cancer.
PMID: 26222778
Ref: Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells.
PMID: 27699933
Ref: Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy.
PMID: 27708223
Ref: Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
PMID: 27878243
Ref: High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.
PMID: 28005260
Ref: Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy.
PMID: 28028179
Ref: A food-based approach that targets interleukin-6, a key regulator of chronic intestinal inflammation and colon carcinogenesis.
PMID: 28193578
Ref: MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3.
PMID: 30186040
Ref: Lyophilized acai pulp (Euterpe oleracea Mart) attenuates colitis-associated colon carcinogenesis while its main anthocyanin has the potential to affect the motility of colon cancer cells.
PMID: 30194994